Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 and up

Cyanoacrylate glue versus collagen sponge for healing palatal donor wounds

Official title: Effect of Cyanoacrylate Tissue Adhesive Versus Collagen Sponge on Palatal Donor Site Healing After Harvesting a Free Gingival Graft: a Randomized Controlled Clinical Trial

Run by Beirut Arab University · NCT07086482 · Data updated 2026-11-12

This test compares cyanoacrylate glue (PeriAcryl) and collagen sponge to see which helps adult patients' palatal donor sites heal faster and feel more comfortable after a free gingival graft.

More Wound trials

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment22 (estimated)
SponsorBeirut Arab University
Academic / other
Locations1 site (Beirut)
StatusRecruiting
StartedAugust 4, 2025
Main results expectedMarch 20, 2026
Study endsApril 20, 2026
Registry record updatedAugust 17, 2025
Trial IDNCT07086482 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults in good general health (ASA I-II) who need a free gingival graft, have healthy gingiva with low plaque and bleeding scores, and can attend follow-up visits are ideal candidates.

Probably not a fit

Patients with systemic diseases, coagulation disorders, heavy smokers (>10 cigarettes/day), pregnant or lactating individuals, or those with relevant drug/allergy issues are unlikely to benefit and are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center interventional Early Phase 1 trial at Beirut Arab University compares cyanoacrylate tissue adhesive (PeriAcryl) to a collagen sponge for managing palatal donor wounds after free gingival graft harvesting. Eligible healthy adult patients are assigned to either PeriAcryl applied over the wound or a collagen sponge stabilized with sutures, then followed at scheduled visits to monitor healing and complications. Primary outcomes are wound healing and re-epithelialization, while secondary outcomes include patient satisfaction and oral-health–related quality of life. Clinical exams and patient-reported measures will document healing speed, postoperative symptoms, and any adverse events.

Why it matters

Potential benefit: If successful, PeriAcryl could speed palatal wound healing, reduce postoperative pain and complications, and improve patient comfort after graft harvesting.

How similar studies have gone: Cyanoacrylate adhesives have been used successfully for oral soft-tissue closure in prior reports, but randomized comparisons specifically against collagen sponge for palatal donor sites are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Low-moderate anesthetic risk (ASA I-II)
* No restriction on ethnicity or gender
* Patients requiring FGG from the palate for periodontal plastic surgery
* Clinically healthy gingiva after phase I therapy
* Full-mouth plaque index grades 0 and 1
* Bleeding scores \<15%

Exclusion Criteria:

* Patients who smoke \> 10 cigarettes/day
* Patients with coagulation disorders
* Systemic diseases
* Patients on certain medications that may affect periodontal tissues
* Pregnant and lactating patient
* Patients with allergies to drugs that will be prescribed during the treatment phase
* Pathological mental conditions (dementia, psychosis) and lack of cooperation
* Excessive gag reflex

Where it's running

  • Beirut Arab University
    Beirut, Lebanon
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.